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Abstract
Recent data suggest that Nef-mediated downmodulation of TCR-CD3 may protect SIVsmm-infected sooty mangabeys (SMs)
against the loss of CD4
+ T cells. However, the mechanisms underlying this protective effect remain unclear. To further assess
the role of Nef in nonpathogenic SIV infection, we cloned nef alleles from 11 SIVsmm-infected SMs with high (.500) and 15
animals with low (,500) CD4
+ T-cells/ml in bulk into proviral HIV-1 IRES/eGFP constructs and analyzed their effects on the
phenotype, activation, and apoptosis of primary T cells. We found that not only efficient Nef-mediated downmodulation of
TCR-CD3 but also of MHC-I correlated with preserved CD4
+ T cell counts, as well as with high numbers of Ki67
+CD4
+ and
CD8
+CD28
+ T cells and reduced CD95 expression by CD4
+ T cells. Moreover, effective MHC-I downregulation correlated with
low proportions of effector and high percentages of naı ¨ve and memory CD8
+ T cells. We found that T cells infected with
viruses expressing Nef alleles from the CD4low SM group expressed significantly higher levels of the CD69, interleukin (IL)-2
and programmed death (PD)-1 receptors than those expressing Nefs from the CD4high group. SIVsmm Nef alleles that were
less active in downmodulating TCR-CD3 were also less potent in suppressing the activation of virally infected T cells and
subsequent cell death. However, only nef alleles from a single animal with very low CD4
+ T cell counts rendered T cells
hyper-responsive to activation, similar to those of HIV-1. Our data suggest that Nef may protect the natural hosts of SIV
against the loss of CD4
+ T cells by at least two mechanisms: (i) downmodulation of TCR-CD3 to prevent activation-induced
cell death and to suppress the induction of PD-1 that may impair T cell function and survival, and (ii) downmodulation of
MHC-I to reduce CTL lysis of virally infected CD4
+ T cells and/or bystander CD8
+ T cell activation.
Citation: Schindler M, Schmo ¨kel J, Specht A, Li H, Mu ¨nch J, et al. (2008) Inefficient Nef-Mediated Downmodulation of CD3 and MHC-I Correlates with Loss of CD4
+
T Cells in Natural SIV Infection. PLoS Pathog 4(7): e1000107. doi:10.1371/journal.ppat.1000107
Editor: Thomas J. Hope, Northwestern University, United States of America
Received December 10, 2007; Accepted June 19, 2008; Published July 18, 2008
Copyright:  2008 Schindler et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by the Wilhelm-Sander Foundation, the Deutsche Forschungsgemeinschaft, Yerkes center grant RR-00165, and NIH R01
grants AI067057, AI058715, AI 050529, and AI66998. The funders had no role in data analysis, preparation of the manuscript, or decision to publish.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: frank.kirchhoff@uniklinik-ulm.de
¤ Current address: Heinrich-Pette-Institut, Hamburg, Germany
Introduction
Although all primate lentiviruses are referred to as human and
simian ‘‘immunodeficiency’’ viruses (HIV and SIV, respectively),
SIVs do generally not cause disease in their natural monkey hosts
[1,2]. This is in contrast to HIV-1-infected humans and SIVmac-
infected macaques, who develop immunodeficiency and AIDS in
the absence of antiretroviral therapy [3]. The exact mechanisms
underlying nonpathogenic SIV infection are still unclear. Viral
loads in naturally infected sooty mangabeys and African green
monkeys are just as high as in HIV-1-infected humans and
SIVmac-infected macaques [4–6]. Furthermore, SIVsmm and
SIVagm replicate efficiently in lymphoid tissues and cause massive
destruction of CD4
+ memory T cells in the gut during acute
infection [7,8]. However, a consistent difference between patho-
genic and nonpathogenic primate lentiviral infections is that high
levels of chronic immune activation associated with accelerated T
cell turnover and apoptosis are observed in HIV-1-infected
humans and SIVmac-infected macaques but not in naturally
SIV-infected primates [1,2]. Increased immune activation is also a
key predictor of progression to AIDS in HIV-1-infected humans
[9,10]. It is thus believed that infection-associated chronic immune
activation and T cell apoptosis drive the progressive destruction of
the human immune system.
One viral factor that modulates viral fitness, persistence and
pathogenicity, is the viral Nef protein. Initially, Nef appeared to
represent a potent ‘‘virulence’’ factor because disrupted nef genes
were associated with very low viral loads and an attenuated
clinical course both in HIV-1 and SIVmac infections [11–13].
Subsequently, a surprising number of different Nef functions have
been described, including modulation of cell surface expression of
CD4, CD28, class I MHC and the invariant chain associated
with immature class II MHC molecules, as well as enhancement
of viral infectivity and replication [14–21]. In pathogenic HIV-1
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promotes viral persistance and accelerates disease progression by
facilitating viral immune evasion and by enhancing viral spread
[22–27]. However, high viral loads are not associated with the
development of disease in natural SIV infection [1,2]. Thus, Nef
does not act as a pathogenesis factor in natural SIV infections.
This may be due to the fact that most primate lentiviral Nef
proteins efficiently downmodulate CD3, a key component of the
T cell receptor (TCR), from the surface of virally infected T cells,
while Nef proteins of HIV-1 and its immediate SIV precursors
fail to perform this function [28]. It is controversial whether the
HIV-1 Nef enhances or reduces the responsiveness of virally
infected T cells to activation [28–36]. However, it is clear that nef
alleles from primate lentiviruses which are capable of down-
modulating TCR-CD3 suppress T cell activation and apoptosis
substantially more efficiently than those that can not perform this
function [28].
Recently, it has been shown that a small subset (10–15%) of
naturally infected SMs experience a significant loss of CD4
+ T
cells during the course of their infection [37,38]. Following up on
this observation, we examined the Nef functions of the viruses
infecting these animals. Interestingly, we found that efficient Nef-
mediated downmodulation of TCR-CD3 was preserved only in
those animals with high CD4
+ T cells, but not in those with low
CD4
+ T cells [28]. This study provided a first indication that Nef
may exert a protective role in natural SIV infections; however, it
had limitations. First, viruses from only few SMs with low CD4
+ T
cells counts were available for study. Second, Nef functions were
only analyzed in Jurkat T cells following transient transfection with
vectors coexpressing Nef and eGFP. Finally, only few Nef
activities, i.e. downmodulation of CD4, CD3, CD28 and MHC-
I, were investigated. In the present study, we examined the effects
of nef alleles from 11 SMs with CD4
+ T cell counts .500 cells/ml
(CD4high Nef) and 15 SMs with CD4
+ T cell counts ,500 CD4
+
(CD4low Nef) on the surface expression of various cellular
receptors, T cell activation and apoptosis of virally infected cells.
Our results show that not only downmodulation of TCR-CD3 but
also of MHC-I correlates with the preservation of CD4
+ T cells in
infected managbeys in vivo. Thus, primate lentiviral Nef proteins
may exert a protective effect in natural SIV infection through two
different yet complementary pathways by preventing activation-
induced cell death of infected CD4
+ T cells as well as CD8
+ T cell
activation and CTL lysis.
Results
Generation of proviral constructs coexpressing primary
SIVsmm Nef alleles and eGFP
To study the function of primary SIVsmm nef alleles from SMs
with different CD4
+ T cell counts, we cloned nef alleles from 15
animals with low (,500/ml) and 11 animals with high (.500/ml)
CD4
+ T cell counts (CD4low and CD4high Nefs, respectively) into
an HIV-1 NL4-3-based IRES-eGFP proviral vector coexpressing
Nef and eGFP from bicistronic RNAs [28,39]. Nef alleles were
amplified from the plasma of 22 naturally and four experimentally
SIVsmm-infected SMs housed at the Yerkes National Primate
Research Center (Atlanta, GA) and cloned in bulk into the
proviral vector (Figure S1). Nef alleles from 19 of these 26 SMs
were previously cloned into the bicistronic pCGCG expression
plasmid and analyzed in Jurkat T cells by transient transfection
[28]. The virological and immunological characteristics of this SM
colony, particularly the correlates of CD4
+ T cell depletion have
recently been described [37]. The 15 ‘‘CD4low’’ animals include
12 of 14 previously reported naturally SIVsmm-infected SMs with
CD4
+ cell counts ,500/ml [37]. The remaining three CD4low
animals were infected by i.v. injection of plasma from a naturally
SIVsmm-infected SM [38].
Molecular characterization of SIVsmm nef alleles
Phylogenetic analyses of amplified nef sequences verified that all
proviral plasmid preparations contained nef alleles from different
animals. Moreover, to ensure appropriate representation of the nef
alleles present in vivo viral stocks were derived from $50
independent transformants (data not shown). Alignment of the
deduced amino acid sequences showed that several domains and
putative protein interaction sites previously described to be
relevant for HIV-1 Nef function [40] were conserved in SIVsmm
Nefs, including the N-terminal myristoylation signal, the acidic
region, a diarginine motif, a C-proximal adaptor-protein interac-
tion site and a diacidic putative V1H binding site (Figure 1). In
comparison, the P(xxP)3 motif, which is highly conserved in HIV-
1 Nef’s and interacts with cellular kinases [40], is not conserved in
SIVsmm Nef alleles, which usually contain only two proline
residues at this location (Figure 1).
Inspection of the Nef sequences from CD4high and CD4low
groups of SMs failed to reveal obvious inactivating mutations, such
as large deletions or premature stop codons. However, Nef
sequences from the CD4low group were more likely to contain
changes in the N-proximal region (residues 31 to 40), the acidic
motif and the region downstream of the proline-rich region.
Moreover, changes in S63 or E64 were observed in 11 of 15
CD4low but only in 1 of 11 CD4high Nef alleles (Figure 1).
Finally, substitutions of S138, E139, E191, Q221 and T225 just
upstream of the ‘‘diarginine motif’’, the ‘‘dileucine’’-based sorting
signal (ExxxLV) [41], and Y226 were substantially more frequent
in Nef alleles from the CD4low group of SMs. Y226 corresponds
to Y223 in the SIVmac239 Nef and is required for MHC-I
downmodulation but not for other Nef activities [24,42].
Altogether, the sequence comparisons indicated that SIVsmm nef
genes from SMs with both high and low CD4
+ T cell counts
encoded full-length Nef proteins but frequently differed in amino
acid residues flanking known functional motifs.
Author Summary
The accessory Nef protein is commonly considered a
‘‘pathogenicity’’ factor of primate lentiviruses. However,
SIVs do not cause disease in their natural hosts, although
they all encode nef genes and sustain high levels of
viremia. To better understand the role of Nef in natural
nonpathogenic SIV infection, we compared the function of
Nef alleles from two groups of SIVsmm-infected sooty
mangabeys: (i) those that maintained normal CD4
+ T cell
counts and (ii) a small subset (10%–15%) of animals that
exhibited a considerable loss of CD4
+ helper T cells. We
found that the efficiency of two specific Nef functions, i.e.,
downmodulation of TCR-CD3 and MHC-I, correlated with
preserved CD4
+ T cell homeostasis, as well as with other
immunological features, such as high numbers of prolif-
erating CD4
+ Ki67
+ T cells. Moreover, lack of CD3 surface
expression was associated with low levels of apoptosis and
PD-1 expression by virally infected T cells. Thus, the ability
of Nef to remove TCR-CD3 and MHC-I from the cell surface
may help the natural hosts of SIV to maintain normal CD4
+
T cell counts despite high levels of viral replication by
preventing activation-induced cell death and CTL lysis of
infected T cells and/or CD8
+ T cell activation.
Protective Nef Functions
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correlates with high CD4
+ T cell counts in SIVsmm-
infected SMs
As reported previously [28], the proviral NL4-3 Nef/eGFP
constructs are isogenic except for their nef coding sequences and
have the advantage that Nef expression is mediated by the viral
LTR promoter and via the normal splice sites. Moreover,
pseudotyping with the VSV-G envelope protein bypasses the
effect of Nef on virion infectivity [43] and hence allows to
transduce primary T cells with comparable efficiency indepen-
dently of their nef coding regions. Finally, since infected cells
coexpress Nef and eGFP from single bicistronic RNAs, Nef
expression can be correlated with receptor expression levels,
activation status and apoptosis [28,39]. To compare the potency of
primary SIVsmm nef alleles from SMs with differential CD4
+ T
cell counts in downmodulating CD3, CD4, CD28, MHC-I and
CXCR4, we transduced Jurkat T cells with the proviral constructs
and analyzed them by flow cytometry (examples shown in Figure
S2). Consistent with earlier results [28], we found that CD4high nef
alleles were significantly more active in TCR-CD3 downmodula-
tion than those from the CD4low animals (7.260.8, n=11 vs
4.260.5, n=15; P=0.0033; numbers give average n-fold down-
modulation 6SD) (Figure 2). However, the present analysis of a
larger number of nef alleles also revealed significant differences in
MHC-I downmodulation between the CD4high and CD4low
groups (3.060.1, n=11 vs 2.360.1, n=15; P=0.0023). Exclusion
of nef genes from four experimentally infected SMs did not change
these results: the differences in CD3 and MHC-I modulation
remained significant (P=0.027 and P=0.011, respectively). In
comparison, the two sets of nef alleles did not differ significantly in
their abilities to downmodulate CD4, CD28 and CXCR4 from
the surface of infected Jurkat cells. Notably, the detectable effect of
Nef on CD4 was weak because the proviral constructs express Vpu
and Env which also downmodulate this receptor [44,45]. Since
SIVsmm specific Nef antibodies are not available, the contribution
of Nef expression levels to the observed functional differences
could not be assessed. However, the fact that the majority of nef
alleles were functionally active at least in some assays implies that
they are efficiently expressed.
Next, we examined Nef function in human PBMCs infected
with eGFP-expressing reporter viruses (data summarized in Table
S1). Importantly, these experiments were performed in both the
presence and absence of CD8
+ T cells (examples shown in
Figure 2A and S2) to (i) maintain some of the complexity that
Figure 1. SIVsmm Nef sequences do not contain obvious defects. The SIVsmm consensus Nef amino acid sequences from the CD4high
(ConH) and CD4low (ConL) animals are shown in the upper panels. Nef sequences derived from the four experimentally infected SMs are shown in
blue. The order of the SIVsmm Nef alleles corresponds to that of the CD4
+ T cell counts in the respective SMs; i.e. the Nef sequence from animal FNp
with the highest numbers shown at the top and from FYb that showest the most severe CD4
+ T cell depletion at the bottom. Some conserved
sequence elements in Nef, including the N-terminal myristoylation signal, N-proximal tyrosines, PA residues critical for CD4 down-modulation by
SIVmac Nef, the basic, acidic and proline-rich regions, a diarginine motif, a C-proximal adaptor-protein (AP) interaction site, a diacidic putative V1H
binding site and a Y residue involed in MHC-I downregulation are indicated. Dots specify identity with the consensus Nef sequence and dashes gaps
introduced to optimize the alignment. PCR-fragments amplified from SM plasma were sequenced directly and ‘‘X’’ indicates nucleotide ambiguity in
the corresponding codons.
doi:10.1371/journal.ppat.1000107.g001
Protective Nef Functions
PLoS Pathogens | www.plospathogens.org 3 July 2008 | Volume 4 | Issue 7 | e1000107exists in vivo and (ii) to ensure that transduction of CD8
+ T cells
(that are usually not infected with SIV and HIV) does not impact
the results. Flow cytometric analyses of virally infected PBMCs
confirmed the correlation between efficient TCR-CD3 (4.060.3
vs 2.460.2; P=0.0002) and MHC-I (2.860.1 vs 2.260.1;
P=0.0004) downmodulation and preserved CD4
+ T cell counts
(Figure 2B, middle). On average, PBMCs infected with reporter
viruses containing CD4high nef alleles also expressed lower levels
of the CD4 molecule, but this difference was less pronounced. In
comparison, the effect of all SIVsmm nef alleles on CD28 and
CXCR4 surface expression on PBMCs was weak and did not
differ significantly between the CD4high and CD4low groups.
CD8-depleted PBMC cultures yielded identical results (Figure 2B,
right). Finally, correlation analyses demonstrated that all nef alleles
that efficiently downmodulated CD4, TCR-CD3 and MHC-I in
Jurkat cells were also highly active in PBMCs (Figure S3).
To further evaluate the role of TCR-CD3 and/or MHC-I
downmodulation by Nef in the maintenance of stable CD4
+ T cell
numbers, we performed correlation analyses. As shown in
Figures 3A and S4A, the efficiency of these Nef functions
correlated with the numbers of CD4
+ T cells in SIVsmm-infected
SMs in vivo. The correlations between both absolute and relative
CD4
+ T cell counts and the potency of Nef-mediated down-
modulation of TCR-CD3 or MHC-I by Nef remained significant
when only the 22 naturally SIVsmm-infected animals were
included in the analyses (Figures 3A, 3B and S4A, S4B). The
strongest correlation between high numbers or percentages of
CD4
+ T cells and Nef function was obtained for the sum of TCR-
CD3 and MHC-I downmodulation (Figure S4C, S4D), suggesting
that both functions synergize to protect SIVsmm-infected SMs
against the loss of CD4
+ T cells.
Correlation between Nef function and immunological
features of SIVsmm infection
We next examined whether these specific Nef functions
correlated with additional virological or immunological parame-
Figure 2. SIVsmm nef alleles derived from CD4high SMs are particularly active in downmodulating CD3 and MHC-I. (A) Surface
expression of CD3, CD4 and MHC-I on PBMCs infected with HIV-1 Nef/eGFP constructs expressing eGFP alone (nef-) or together with indicated nef
alleles. 239 specifies the SIVmac239 Nef. (B) Quantitative assessment of Nef-mediated downmodulation of the indicated cellular receptors on Jurkat
cells, PBMCs and CD8-depleted PBMCs. SIVsmm nef genes were grouped by CD4
+ T cell counts of the animals from which they were amplified and are
color coded red and green, respectively. Each symbol represents n-fold down-modulation of the indicated receptor molecule by one of the 26 NL4-3
recombinants expressing primary bulk SIVsmm nef alleles analyzed. Similar results were obtained in two independent experiments. P-values ,0.05
are indicated.
doi:10.1371/journal.ppat.1000107.g002
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Figures 3C and S5A, we found that the efficiency of Nef-mediated
downmodulation of CD3 correlated with higher numbers of
proliferating CD4
+Ki67
+ cells in SIVsmm-infected SMs. The
same trend was observed for modulation of MHC-I by Nef but
failed to reach significance (Figures 3C, S5A). In addition, we
observed a significant inverse correlation between the efficiency of
both TCR-CD3 and MHC-I downmodulation and the levels of
CD95 expression by CD4
+ T cells (Figures 3D, S5B), suggesting
that the levels of CD95-mediated apoptosis of CD4
+ T cells as well
as their effect on CD8
+ bystander T cells [46] may be reduced in
SMs infected with SIVsmm Nef variants that effectively down-
modulate CD3 and MHC-I. We also found that efficient CD3 and
MHC-I downmodulation correlated with higher numbers of
CD8
+CD28
+ T cells (Figures 3E, S5C). Notably, it has been
shown previously that decreases in the absolute numbers of
CD8
+CD28
+ T cells are predictive for progression to AIDS in
HIV-1 infected individuals [47] and associated with declining
CD4
+ T cell counts in SIV-infected SMs [37]. Finally, we
observed that the number of naı ¨ve CD4
+ T cells correlates with
the efficiency of MHC-I but not TCR-CD3 downmodulation by
Nef (Figures 3F, S5D). In contrast, we did not find significant
correlations between Nef function and other immological
parameters examined, such as the absolute numbers of CD8
+ T
Figure 3. Correlation between Nef-mediated CD3 and MHC-I downmodulation in virally infected PBMCs and immological features
in SIVsmm infected SMs. Correlation between (A) the absolute numbers or (B) percentages of CD4
+ T-cells, (C) number of proliferating CD4
+Ki67
+
T cells, (D) CD95 expression levels of CD4
+ T-cells, (E) number of CD8
+CD28
+ T cells and (F) percentage of naı ¨ve CD4
+ T cells in SIVsmm-infected SMs
and n-fold downmodulation of CD3 and MHC-I. Assays were performed in PBMCs and statistical analysis was performed using the PRISM 4:0 package.
The numbers of CD4
+ T cells obtained from four experimentally infected SMs are indicated by diamond symbold in panel A; all remaining data were
derived from naturally SIVsmm-infected animals. P and R
2 values derived from naturally SIVsmm-infected SMs are shown in black, those including the
four experimentally infected animals in blue.
doi:10.1371/journal.ppat.1000107.g003
Protective Nef Functions
PLoS Pathogens | www.plospathogens.org 5 July 2008 | Volume 4 | Issue 7 | e1000107cells and the levels of proliferating (i.e. Ki67
+) CD8
+ T cells or of
activated (i.e. CD69
+ or HLA DR
+), effector (i.e. CD127
2) and
regulatory CD25
+CD4
+ T cells.
To identify further possible consequences of TCR-CD3 and
MHC-I downmodulation, we compared the immunological and
virological features of SMs naturally infected with SIVsmm
expressing nef alleles showing the highest (n=6) or lowest (n=6)
activities in these two functions, i.e. .4.0- vs ,2.1-fold and .2.8-
vs ,2.2-fold downmodulation in PBMCs. While the results of
subgroup analyses need to be interpreted with caution they are a
meaningful approach to generate and assess new hypotheses [48].
This analysis confirmed that lack of these Nef functions correlates
with reduced numbers and/or percentages of CD4
+ T cells,
CD4
+Ki67
+ and CD8
+CD28
+ T cells in SIVsmm-infected SMs
(Figure 4A–D) but not with significant differences in viral loads
(Figure 4E). As expected from the results of the correlation
analyses (Figure 3F), efficient MHC-I but not TCR-CD3 down-
modulation by Nef was associated with a reduced number of naı ¨ve
CD4
+ T cells in SIVsmm-infected SMs (Figure 4F). Furthermore,
this comparative analysis showed that the percentage of effector
CD8
+ T cells is significantly lower and that of naı ¨ve and memory
CD8
+ T cells significantly higher in animals infected with SIVsmm
strains that effectively downregulated MHC-I (Figure 4G–I). We
also observed a trend for higher percentages of CD8
+CCR7
+ T
cells (Figure 4J). Taken together, these data demonstrate that
effective TCR-CD3 and MHC-I downmodulation by Nef is a
strong correlate of preserved CD4
+ T cells counts in natural
SIVsmm infection of SMs and further support that inefficient
MHC-I antigen presentation by virally infected cells affects the
CD8
+ T cell response.
Nef-mediated suppression of T cell activation and
apoptosis correlates with preserved CD4
+ T cell counts in
SMs
We have previously shown that TCR-CD3 downmodulation by
Nef blocks the responsiveness of virally infected T cells to
activation [28]. To assess whether the relatively subtle functional
differences of primary SIVsmm nef alleles in TCR-CD3 modula-
tion are also associated with differential responsiveness of infected
T cells to stimulation we first determined the surface expression
levels of CD69 and of the IL-2 receptor-a chain (IL-2Ra)o r
CD25, well known markers for early and late T cell activation, in
HIV-1-infected PHA-treated regular and CD8-depleted PBMC
cultures. These analyses showed that T cells infected with viruses
expressing CD4high Nef alleles expressed significantly lower levels
of activation markers than those infected with CD4low Nef
constructs (Figures 5A, S6A). In agreement with our previous data
[28], suppression of CD69 and IL-2R expression correlated with
effective downmodulation of TCR-CD3 (Figures 5B, S6B, S6C)
and reduced levels of programmed death (Figure 5C). Further-
more, Nef-mediated downmodulation of CD3 (Figure 5D) but not
that of MHC-I (Figure 5E), correlated with reduced percentages of
apoptotic cells. Although downmodulation of CD3 and MHC-I
are mediated by different domains in Nef [24,26,49–51], both
Figure 4. Immunological features in SMs infected with SIVsmm strains differing in their ability to downmodulate TCR-CD3 and
MHC-I. Comparison of (A) the absolute numbers or (B) percentages of CD4
+ T-cells; (C) number of proliferating CD4
+Ki67
+ T cells; (D) absolute
number of CD8
+CD28
+ T cells; (E) viral load; (F) percentages of naı ¨ve CD4
+ and of (G) effector, (H) naı ¨ve, (I) memory and (J) CD8
+ CCR7
+ T cells cells in
SMs naturally infected with SIVsmm expressing nef alleles showing the highest (n=6, green bars) or lowest (n=6, red bars) activities of the 22
naturally infected animals analyzed. Indicated are average values 6SEM. Numbers above the bars indicate P values; ns, not significant.
doi:10.1371/journal.ppat.1000107.g004
Protective Nef Functions
PLoS Pathogens | www.plospathogens.org 6 July 2008 | Volume 4 | Issue 7 | e1000107functions correlated with one another (Figure 5F), suggesting that
both may be coselected in SIVsmm-infected SMs.
Recent findings suggest that high levels of programmed death
(PD)-1 receptor expression contribute to the exhaustion of HIV-1-
specific CD8
+ T cells because blocking PD-1-PD-1 ligand
interaction enhanced their ability to proliferate and to produce
cytokines in HIV-1 infected individuals [52,53]. PD-1 is also
expressed on activated CD4
+ T cells [54,55] and its blockade partly
restored CD4 proliferative responses in AIDS patients [52]. It has
been shown that PD-1 is inducibly expressed on activated T cells
[56]. Since CD3 downmodulation prevents T cell activation, we
examined whether this Nef function affects the induction of PD-1
expression by virally infected T cells. We found that PHA
stimulation induced a 2.5- to 4-fold increase in PD-1 expression
levels (example shown in Figure 6A). Infection with HIV-1
constructs expressing no Nef or Nef alleles that do not down-
modulate TCR-CD3 resulted in slightly increased levels of PD-1
expression. In strict contrast, those that downregulated TCR-CD3
generally suppressed the induction of this receptor (Figure 6A).
Further analyses demonstrated that Nef alleles from the CD4high
group of SMs suppressed the induction of PD-1 expression
significantly more efficiently than those derived from the CD4low
group of animals (Figure 6B). Since both represent T cell activation
markers, we observed a highly significant correlation between the
levels of IL-2R and PD-1 expression on HIV-1 infected PBMCs
(Figure 6C). Suppression of the induction of PD-1 expression
correlated with the efficiency of TCR-CD3 downmodulation
(Figure 6D). The correlation between the ability of Nef to
downmodulate CD3 and to suppress the induction of CD69, PD-
1 and IL-2R was confirmed using CD8-depleted PBMCs (Figure
S6).Thus, the ability of Nefto modulate TCR-CD3 may impactthe
functionality, proliferation and survival of T cells by affecting the
expression levels of PD-1 on virally infected CD4
+ cells.
Nef alleles from an SM with extremely low CD4
+ T cell
counts render T cells hyper-responsive to activation
The nuclear factor of activated T cells (NFAT) regulates
transcription of IL-2 gene expression, a hallmark of T cell
activation. It has been established that NFAT activation is
suppressed by Nef alleles that downmodulate TCR-CD3, e.g.
SIVsmm and HIV-2 Nefs, and enhanced by Nef alleles that do not
modulate this receptor, such as those of HIV-1 [28,31]. To assess
whether nef alleles from the CD4high and CD4low groups of
SIVsmm-infected SMs differentially affect NFAT induction in
virally infected cells, we transduced Jurkat T cells stably
transfected with the luciferase gene under the control of an
NFAT-dependent promoter [31], with the proviral HIV-1 eGFP/
Nef constructs and examined their responsiveness to activation. T
cells infected with nef defective HIV-1 showed about 5-fold
enhanced levels of NFAT activity after PHA stimulation compared
to mock infected cells (Figure 7A). This increase was usually
further enhanced by 2- to 3-fold by expression of HIV-1 and
SIVcpz Nef alleles but blocked by the control SIVmac and HIV-2
Nefs (examples shown in Figure 7A). SIVsmm Nef alleles from 25
of the 26 infected SMs also suppressed NFAT induction, albeit
with differential efficiency. Interestingly, nef alleles from animal
FYb, that showed the most severe CD4
+ T cell depletion (3/ml) of
the entire colony of 110 naturally SIVsmm-infected SMs [37],
rendered the Jurkat T cells hyper-responsive to activation - just like
those of HIV-1 (Figure 7A). This unusual property of bulk FYb
Nef alleles, which were generally poorly active in other functions
including downmodulation of CD3 and MHC-I, was confirmed
using 18 HIV-1 IRES/eGFP constructs expressing individual FYb
derived Nef proteins (data not shown).
Compared to FYb, the NFAT-dependent luciferase activities
were 4- to 13-fold lower in Jurkat cells infected with viral
constructs expressing Nef alleles derived from the remaining 25
Figure 5. Effect of SIVsmm Nef alleles on IL-2R expression and apoptosis. (A) Levels of IL-2R expression on PBMCs transduced with HIV-1
constructs expressing Nef alleles from SIVsmm-infected SMs with low or high CD4
+ T-cell counts. The mean fluoresence activities (MFIs) of IL-2R
expression were determined at 4 days post-stimulation. (B, C) Correlation between IL-2R expression levels and (B) the efficiency of Nef-mediated CD3
downmodulation or (C) the percentage of apoptotic cells (n=22). (D, E) Correlation between (D) TCR-CD3 and (E) MHC-I downmodulation and
apoptosis. (F) Correlation between TCR-CD3 and MHC-I downmodulation.
doi:10.1371/journal.ppat.1000107.g005
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NFAT induction than those from the CD4high group (Figure 7B).
The levels of NFAT activation in HIV-1-infected T cells inversely
correlated with the CD4
+ T cell counts of the respective SIVsmm-
infected SMs in vivo, although this correlation was not very
stringent (Figure 7C). In comparison, the ability of these 25 nef
alleles to suppress NFAT induction upon PHA stimulation did not
correlate with their potency in downmodulating TCR-CD3
(Figure 7D). This is most likely due to the fact, that the functional
differences in modulation of TCR-CD3 between these SIVsmm nef
alleles are much more subtle than those between Group 1 and 2 nef
alleles [28], and that other Nef functions, such as downmodulation
of CD4, CD28 and CXCR4, also affect the responsiveness of
virally infected T cells to activation. Nevertheless, these results
further support that high responsiveness of infected T cells to
activation accelerates the loss of CD4
+ T cells in naturally SIV-
infected SMs.
Enhancement of virion infectivity by primary SIVsmm nef
alleles
In addition to facilitating viral immune evasion, Nef has been
reported to also enhance virion infectivity [14,15,17,18]. To
examine whether CD4
+ T cell loss in SIVsmm-infected SMs is
associated with differences in this Nef function, we exposed the
HeLa-CD4/LTR-lacZ indicator cell line, P4-CCR5, which
expresses CD4 and both major entry cofactors CXCR4 and
CCR5 [57,58], to 293T cell-derived virus stocks and determined
the b-galactosidase activities after two days. Most bulk SIVsmm nef
alleles enhanced virion infectivity, albeit with varying efficiencies
(Figure 8A). Analysis of the same reporter viruses using the TZM-
bl indicator cell line, previously designated JC53-bl [59,60],
yielded the same results (Figure 8B). On average, nef genes from
SIVsmm-infected SMs with high CD4
+ T cell counts were slightly
more active in enhancing virion infectivity than those from
animals with low numbers of CD4
+ T cells (Figure 8C). However,
this difference was mainly due to the unusually high activity of nef
alleles from a single animal (FAi) and not significant. Moreover,
the potency of Nef in enhancing virion infectivity did not correlate
with the CD4
+ T cell counts in SIVsmm-infected SMs (Figure 8D).
Impact of specific amino acid substitutions on SIVsmm
Nef function
To analyze the effect of sequence variations between the
CD4high and CD4low groups of SMs on Nef function we
synthesized the consensus nef sequences derived from the six
animals with the highest (SMhi) and the six SMs with the lowest
(SMlow) numbers of CD4
+ T cells, which differed in a total of 20
amino acid residues (Figure S7A). We found that the SMhi Nef
allele was moderately more active in downmodulating CD3 and
MHC-I and in suppressing T cell activation and programmed
death than the SMlow consensus Nef (Table S2). Thus, the SMhi
and SMlow Nef alleles exhibited functional differences reflecting
Figure 6. Nef-mediated TCR-CD3 downmodulation correlates with suppression of PD-1 expression. (A) Surface expression of PD-1 on
PBMCs that were either not stimulated (unstim.) or stimulated with PHA for 2 days and either not infected or transduced with HIV-1 Nef/eGFP
constructs expressing eGFP alone (nef-) or together with the NL4-3 or mac239 nef alleles. eGFP expression levels used to calculate receptor down-
modulation and the MFIs are indicated. Control, unspecific background. (B) Quantitative assessment of PD-1 expression on PBMCs infected with HIV-1
constructs expressing SIVsmm nef genes from the CD4low and CD4high groups of SMs. Each symbol represents the PD-1 expression level on PBMCs
infected by one of the 26 NL4-3 recombinants expressing primary bulk SIVsmm nef alleles analyzed. Similar results were obtained in two independent
experiments. (C, D) Correlation between (C) the levels of IL-2R and PD-1 expression on HIV-1 infected PBMCs and (D) PD-1 surface levels and the
efficiency of CD3 downmodulation by the corresponding Nef alleles. (E) Correlation between PD-1 expression by virally infected PBMCs in vitro and
the CD4+ T cell counts in SIVsmm-infected SMs.
doi:10.1371/journal.ppat.1000107.g006
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high and low CD4
+ T cell counts. However, both consensus Nefs
were more active than most primary Nef alleles. This phenotype is
similar to that of consensus Nef alleles from HIV-1-infected
individuals with progressive and nonprogressive infection, which
also displayed unusually high activity and only subtle functional
differences [23]. The reason for this phenotype is most likely that
these consensus Nefs contain optimal amino acid residues at most
positions, although the possibility that they may be expressed at
particularly high levels cannot be exluded.
To further assess which amino acid variations modulate the ability
of Nef to downregulate CD3 and MHC-I we analyzed about 50
individual primary SIVsmmnefalleles. The results confirmed the data
obtained from the analyses of Nef function in bulk. For example, the
FCs clone 1 Nef allele derived from a CD4high SM efficiently
downmodulated CD3 and suppressed T cell activation, whereas the
FYb clone 17 Nef from a CD4low animal was poorly active (Table
S2). To map residues underlying these functional differences, we
replaced eight amino acid residues in the FCs clone 1 Nef with the
corresponding residues in FYb and introduced the reverse changes in
the FYb clone 17 Nef (Figure S7B). Our data showed that these
changes impaired the activity of the FCs clone 1 Nef in receptor
downmodulation but rendered it active in causing hyper-responsive-
ness of T cells to activation–similarly to those of FYb. In contrast, the
reverse changes partially restored the ability of the FYb clone 17 Nef
to downmodulate CD3 and to suppress T cell activation and
programmed death (Table S2). Interestingly, one of 15 nef alleles
(clone 8) from another animal (FBr) was impaired in CD3 but not in
Figure 7. Impact of SIVsmm Nef alleles on NFAT induction. (A) Analysis of Jurkat cells stably transfected with an NFAT-dependent reporter
gene [31] following transduction with the indicated HIV-1 Nef/eGFP constructs and subsequent stimulation with PHA. Levels of NFAT-dependent
luciferase reporter activity are the average (6SD) of triple infections. Similar results were obtained in two independent experiments. Mock specifies
uninfected control cells. The levels of luciferase activity in mock and nef-defective HIV-1 infection are indicated by broken lines. (B) N-fold induction of
NFAT in T cell cultures infected with HIV-1 variants expressing Nef alleles from SIVsmm-infected SMs with low (n=14) or high (n=11) CD4
+ T-cell
counts compared to the mock control. Squares indicate Nef alleles derived from naturally infected SMs and diamonds those from experimentally
infected animals. Animal FYb (see panel A) was excluded from the analyses shown in panels B–D. (C, D) Correlation between (C) the CD4
+ T cell
counts in SIVsmm infected SMs and (D) the efficiency of Nef-mediated CD3 downmodulation and PHA-induced levels of NFAT-dependent luciferase
activities (n=25).
doi:10.1371/journal.ppat.1000107.g007
Protective Nef Functions
PLoS Pathogens | www.plospathogens.org 9 July 2008 | Volume 4 | Issue 7 | e1000107CD4 or CD28 downmodulation (Figure 9A). Since it differed in only
eight amino acid residues from active FBr Nef alleles (Figure S7C;
Table S2), we introduced all eight changes (five individually and the
RKT to HRV substitution in the ‘‘P-rich’’ region in combination)
into the FBr clone 8 Nef. Unexpectedly, only a homologous L123I
change specifically enhanced its activity in CD3 downmodulation,
while the reverse I123L substitution in the active FBr clone 6 Nef
increased its ability to modulate CD3 even further (Figure 9A; Table
S2). Thus, although the determinants of CD3 downmodulation by
SIVsmm Nef are obviously complex and dependent on the specific
Nef backbone, residue I123 seems to be specifically involved in Nef-
mediated modulation of CD3 but not of other surface receptors.
Further mutational analyses of SIVsmm Nef alleles differing in
specific functions due to a limited number of amino acid substitutions
should allow to pinpoint the critical residues.
Discussion
In the present study we performed a detailed functional analysis
of Nef proteins from naturally infected SM with different infection
outcomes. Our results show that inefficient downmodulation of
TCR-CD3 by SIVsmm Nef alleles correlated with the loss of
CD4
+ T cells. In other words, a more ‘‘HIV-1-like’’ Nef phenotype
of SIVsmm, i.e. the inability to efficiently downregulate TCR-
CD3, was associated with a course of SIVsmm infection that was
more reminiscent of pathogenic HIV-1 infection. At first view it
may seem paradoxical that downmodulation of TCR-CD3 - a
molecular complex essential for the function of T cells–may
protect against the development of immunodeficiency. However,
at least during chronic infection only a small fraction of CD4
+ T
cells is productively infected. Thus, it is conceivable that their
functionality is not critical for the overall immune competence of
the infected host. The rate at which these virally infected T cells
die and must be replaced, however, must have a significant impact
on the host’s regenerative capacity. Furthermore, CD4
+ helper T
cells orchestrate the immune response and are typically able to
exert significant effects on the immune system by relatively small
numbers. Thus, virally infected activated CD4
+ T cells likely
contribute to high levels of immune activation by sequestering
cytokines that induce the migration and inflammatory response of
uninfected bystander cells. It is thus possible that a Nef-mediated
suppression of CD4
+ T cell activation and cell death contributes to
a general reduction of infection-associated immune activation.
Notably, our findings likely underestimate the real impact of Nef’s
ability to downmodulate TCR-CD3 on the rates of CD4
+ T cell
depletion because the functional differences between nef alleles
from the CD4low and CD4high groups of SIVsmm-infected SMs
are substantially more subtle than those between HIV-1 and the
great majority of SIVs that are usually highly effective in removing
TCR-CD3 from the cell surface [28].
In our previous study [28], we observed a nonsignificant trend for
more efficient MHC-I downmodulation by CD4high Nefs. The
present analysis of a larger number of SIVsmm infections now
reveals a significant correlation between efficient MHC-I down-
modulation and stable high CD4
+ T cell counts. A protective role of
this Nef function is consistent with the observation that HIV-1 nef
alleles from some long-term nonprogressors remain competent in
downregulating MHC-I but are otherwise defective [61,62]. We
also found that effective Nef-mediated MHC-I downmodulation is
associated with low percentages of effector but high proportions of
Figure 8. Enhancement of viral infectivity by primary SIVsmm Nef alleles. (A) P4-CCR5 indicator cells were infected with HIV-1 NL4-3 IRES-
eGFP constructs containing the indicated SIVsmm nef genes or defective nef alleles. Infections were performed in triplicate with two different virus
stocks containing 1 ng p24 antigen. Shown are average values of the 6 measurements 6SD compared to the infectivity of the virus expressing the
SIVmac239 Nef (100%). Nef alleles derived from experimentally infected animals are indicated by stars. (B) Correlation between the infectivity of HIV-1
NL4-3 IRES-eGFP constructs expressing primary SIVsmm Nef alleles (n=26) in P4-CCR5 and TZM-bl cells. (C) Comparsion of virion infectivity
enhancement by SIVsmm Nef alleles from animals with high (green) or low (red) numbers of CD4
+ T cells. (D) Correlation between the number of
CD4
+ T cells in SIVmm infected SMs and the infectivity of the respective HIV-1 IRES-eGFP nef recombinants (n=26).
doi:10.1371/journal.ppat.1000107.g008
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+T cells(Figure 4G–I).This isinagreement
withpublisheddatashowing that weakMHC-antigen stimulation of
CD8
+ naı ¨veprecursors favors the generationofmemory ratherthan
effector CD8
+ T-cells [63] and that SIVmac mutants selectively
impaired in MHC-I downmodulation cause stronger CD8
+ T-cell
responses [26]. Finally, efficient downmodulation of both CD3 and
MHC-I by Nef correlated with higher numbers of CD8
+CD28
+ T
cells.While further studies arerequired to understand the functional
significance of these associations, it is tempting to speculate that
efficient MHC-I downregulation by Nef may contribute to the
maintenance of high CD4
+ T cells in naturally infected primates by
two different mechanisms, i.e. by reducing CTL lysis of virally
infected CD4
+ T cells and by diminishing the levels of CD8
+
bystander T cell activation.
Accumulating evidence suggests that primate lentiviral Nef
proteins generally promote viral persistance in the infected host by
facilitating immune evasion (i.e. by modulation of CD4, MHC-I
and Ii surface expression) and by enhancing viral infectivity and
replication [28,64,65]. Thus, Nef is most likely critical for the
development and maintenance of high viral loads in natural as well
as in recent and nonnatural SIV and HIV infections. However,
Nef proteins from most SIVs and from HIV-2 also appear to exert
a protective effect that is linked to their ability to downmodulate
CD3 from the cell surface. As shown in the present study, lack of
this Nef function is correlates with a decline in CD4
+ T cells in
primates that usually do not loose their CD4
+ T cells as a
consequence of SIV infection. Whether the reduced ability of Nef
to downmodulate CD3 and MHC-I is the cause or consequence of
CD4
+ T cell decline remains to be investigated. However, there is
no evidence that the quality or the potency of the antiviral
immune response differs in SMs with high or low CD4
+ T cell
counts [37], which argues against the possibility that a more
effective immunity drives the observed functional differences in
Nef. Our new data are thus in agreement with our previous
hypothesis that the evolutionary loss of Nef-mediated down-
modulation of TCR-CD3 contributes to the escalation of immune
activation and the progression to AIDS in HIV-1-infected
individuals [28]. The fact that SIVmac is pathogenic in macaques
(although its Nef downmodulates CD3) does not argue against this
hypothesis. Firstly, this virus does not cause disease or high levels
of immune activation when reintroduced into its original host, the
sooty mangabey [6,66,67]. Thus, the pathogenic phenotype in
macaques seems to be a consequence of an unusually high
susceptibility of this nonnatural host species to SIV-induced
Figure 9. Characterization of an SIVsmm nef allele selectively impaired in CD3 downmodulation. (A) Surface expression of CD3, CD4 and
MHC-I on PBMCs infected with HIV-1 Nef/eGFP constructs expressing eGFP alone (nef-) or together with indicated nef alleles. (B) Quantitative
assessment of Nef-mediated down-modulation of the indicated cellular receptors on PBMCs. Shown are averages 6SD derived from two
independent experiments.
doi:10.1371/journal.ppat.1000107.g009
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the SIV/macaque model increased T cell activation by Nef further
accelerates disease progression [22]. Notably, nef-deleted attenu-
ated HIV-1 infection is ultimately pathogenic in humans unless
replication is completely suppressed [68–70] suggesting that Nef
may accelerate disease progression in nonnatural HIV/SIV hosts
mainly because it increases the viral loads by several orders of
magnitude and not because it enhances virulence directly. These
data suggest that in addition to maintaining high viral loads most
primate lentiviral Nefs also reduce immune activation and T cell
apoptosis and thus the damaging effects associated with these high
viral loads by removing TCR-CD3 from the cell surface.
We have previously shown that TCR-CD3 downmodulation by
Nef inhibits induction of IL-2R expression, NF-AT activation and
activation-induced cell death [28]. Here, we demonstrate that the
efficiency of this Nef function also correlates with the suppression
of the induction of PD-1 expression on virally infected T cells. The
role of this receptor in the pathogenesis of AIDS has received a lot
of attention because it has been shown that high levels of PD-1
expression correlate with declining CD4
+ T cell counts and disease
progression and are associated with reversible dysfunction of
CD4
+ and CD8
+ T cells [52,53]. We thus anticipated that
downmodulation of CD3-TCR would also inhibit the induction of
PD-1 expression because this receptor is expressed predominantly
on activated cells [54,55]. This was indeed observed (Figure 6).
Furthermore, mutations in Nef disrupting CD3 downmodulation
also impaired its ability to suppress PD-1 induction. Conversely, a
truncated form of the SIVmac239 Nef (tNef) that is capable of
downmodulating CD3 but inactive in modulating CD4, MHC-I
and CD28 and enhancing virus infectivity [50], efficiently inhibits
PD-1 induction (data not shown). These data suggest that Nef-
mediated downmodulation of CD3 may be required and sufficient
for the suppression of PD-1 induction, although the possibility that
these Nef mutants differ in additional functions cannot be
excluded. It has been reported that PD-1 inhibits the proliferation
of T cells and sensitizes them for apoptosis [46,71,72]. Thus, high
levels of PD-1 expression should lead to increased programmed
death of infected T cells and may hence accelerate their depletion.
In agreement with this possibility we found that Nef alleles from
SMs experiencing a significant loss of CD4
+ T cells suppressed the
induction of PD-1 less efficiently than those derived from animals
with stable CD4
+ T cell counts. Notably, upregulation of PD-1 on
virally infected CD4
+ T cells may also affect the function of
bystander T and B cells via interactions with its ligands PD-L1 and
PD-L2 [54–56]. Thus, further studies are required to clarify how
differential levels of PD-1 expression on T cells infected with
primate lentiviruses that do or do not downmodulate TCR-CD3
affect the immunological and clinical outcome of infection.
In HIV-1-infected humans, high levels of proliferating
CD4
+Ki67
+ T cells correlate with disease progression [73,74].
However, no correlation between the level of CD4
+Ki67
+ T cells
and signs of disease progression or CD4
+ T cell depletion was
observed in SIV-infected SMs [37]. Unexpectedly, we found
significantly higher numbers of proliferating CD4
+Ki67
+ T cells in
animals infected with SIVsmm Nef variants that maintained high
levels of CD4
+ T cells despite the fact that Ki67 is usually seen as
an activation marker. Since downmodulation of TCR-CD3 and
MHC-I also correlates with reduced expression levels of CD95 on
CD4
+ T cells (Figures 3D, S5B), the higher levels of CD4
+Ki67
+ T
cells may simply reflect the prolonged survival of proliferating
CD4
+ T cells due to reduced levels of apoptosis. As discussed
above, increased PD-1 expression is associated with reduced
proliferative capacity [47,52,53]. Thus, it is tempting to speculate
that Nef-mediated suppression of PD-1 may also contribute to the
high levels of CD4
+Ki67
+ T cells. It has been proposed that
enhanced levels of apoptosis of bystander CD8
+ T cells are
important for the development of AIDS in HIV-1-infected
humans and SIV infected monkeys [46,75]. Thus, it will be of
interest to investigate whether reduced CD95 expression on CD4
+
T cells in SMs infected with SIVsmm variants that effectively
downmodulate TCR-CD3 and MHC-I is associated with reduced
apoptosis of bystander T cells expressing the CD95 ligand.
A striking finding of the present study was that one naturally
infected SM with very low CD4
+ T cell numbers was the only one
of 26 animals investigated which was infected with an SIVsmm
strain whose Nef caused hyper-responsiveness of virally infected T
cells to activation, a phenotype previously established for HIV-1
Nef alleles [31]. It is conceivable that direct enhancement of the
responsiveness of virally infected T cell to activation by Nef may
enhance activation-induced cell death and hence accelerate the
loss of CD4
+ T cells more dramatically than just inefficient
inhibition of these processes. It is noteworthy, however, that this
animal (FYb) did not show unusually high levels of immune
activation and was already of old age [37]. Thus, further studies
are required to clarify the role of Nef’s ability to alter the
responsiveness of infected T cells to activation in the course of
primate lentiviral infection; i.e. it would be of high interest to assess
whether infection of SMs with SIVsmm expressing the FYb nef
allele experience a rapid loss of CD4
+ T cells. Notably, the severe
and persistent loss of CD4
+ T cells in two of the four
experimentally infected SMs examined was not only associated
with inefficient downmodulation of TCR-CD3 but also with the
emergence of SIVsmm variants capable to utilize CXCR4 and
CCR8 in addition to CCR5 [38]. We have initiated studies to
determine the temporal pattern of changes in Nef function and
coreceptor usage and to clarify how the changes in these viral
properties correlate with the loss of CD4
+ T cells. Altogether, these
data suggest that viral properties that are uncommon for SIVs but
not for HIV-1, i.e. an expanded coreceptor tropism and inefficient
suppression of T cell activation, are associated with CD4
+ T cell
depletion even in naturally SIV-infected. Interestingly, none of the
SIVsmm-infected SMs with persistent dramatic CD4+ T cell
depletion developed AIDS [37,38]. Thus, further studies to
elucidate which viral or host factors prevent disease progression
in SIVsmm-infected SMs, even following dramatic CD4
+ T cell
depletion, are highly warranted.
In summary, our data suggest that - in addition to other host
and viral properties [1,2,76] - differences in specific Nef functions
may modulate the immunological outcome of primate lentiviral
infections. In particular, Nef-mediated downmodulation of TCR-
CD3 and MHC-I seem to protect naturally infected SMs against
loss of CD4
+ T cells. Both of these functions presumably delay the
apoptotic death of virally infected T cells, either by suppressing
their activation or by preventing CTL lysis. However, these Nef
functions may also affect the activation and programmed death of
uninfected bystander T cells. The latter is supported by our new
finding that efficient Nef-mediated MHC-I downmodulation is
associated with low numbers of effector and high numbers of
memory CD8
+ T cells. At this point, our data are no definitive
proof that there is a direct causal relationship between Nef-
mediated downmodulation of CD3 and MHC-I and preserved
CD4
+ T cell homeostasis. Instead this will require the testing of
selective SIV Nef mutants in vivo in appropriate SIV/monkey
models, such as SIV-infected SMs or AGMs. Such experiments
should also help to elucidate the role of T cell activation and/or
CTL lysis in CD4
+ T cell depletion and to assess whether
preventing hyperactivation of the immune response would
improve current treatment strategies.
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Animals
Blood samples were obtained from 22 naturally and four
experimentally SIVsmm-infected SMs, all housed at the Yerkes
National Primate Research Center of Emory University and
maintained in accordance with NIH guidelines. These studies were
approved by the Emory University Institutional Animal Care and
Use Committee (IACUC). The virological and immunological
characteristics of these animals have recently been described
[37,38]. Plasma viral RNA was extracted using the QIAamp Viral
RNA Kit (Qiagen) and nef genes were amplified by RT-PCR using
primers SM-Nef-F1 (59-GACAGATAGAATATATTCATTTCC-
39) and SM-Nef-R1 (59-TCTGCCAGCCTCTCCGCAGAG-39).
Sequence analysis of two clones per amplicon (two per animal)
confirmed the integrity of the cloned nef alleles.
Proviral constructs
Generation of HIV-1 (NL4-3 based) proviral constructs carrying
functional nef genes followed by an internal ribosome entry site
(IRES) and the eGFP gene has been described [25,28]. Derivatives
containing stop codons at positions 73 and 74 of the nef ORF
either alone (nef*) or in combination with mutations in the ATG
initiation codon and two in frame stop codons at positions four
and five of the nef ORF (nef-) disrupting the NL4-3 nef gene were
generated by standard PCR and cloning techniques. Splice-
overlap-extension PCR was used to replace the NL4-3 nef gene
with the bulks of SIVsmm nef genes. Briefly, PCR fragments
containing the 39end of the NL4-3 env gene fused to the various
pools of SIVsmm nef genes were cloned into pBR-NL43-IRES-
eGFP-nef
+ using the unique HpaI and MluI sites (Figure S1).
Aliquots of transformed Escherichia coli were plated on Luria broth-
ampicillin dishes to assess transformation efficiency, and the
remaining 90% of the transformed bacteria were used for direct
inoculation of medium-scale plasmid preparations. The percent-
age of the plasmid population containing an SIVsmm nef insert
was estimated by restriction analysis and the integrity of all PCR-
derived inserts was confirmed by sequence analysis. Nef alleles
from 19 of the 26 SMs have been previously analyzed in transient
transfection experiments [28]. Synthetic nef alleles, i.e. SMhi,
SMlow, FCs clone 1mut and FBr clone 17mut, fused to the 39end
of the HIV-1 env gene were synthesized by Epoch Biolabs and
cloned into pBR-NL43-IRES-eGFP vector using the unique HpaI
and MluI sites.
Cell culture
Jurkat and 293T-cells were cultured as described previously
[28]. 293T-cells were maintained in Dulbecco’s modified Eagle’s
medium containing 10% heat-inactivated fetal bovine serum.
PBMC from healthy human donors were isolated using lympho-
cyte separation medium (Biocoll Separating Solution, Biochrom),
stimulated for 3 days with PHA (2 mg/ml) and cultured in
RPMI1640 medium with 10% FCS and 10 ng/ml IL-2 prior to
infection. CD8
+ T cells were depleted from the PBMC cultures
using CD8 MicroBeads (Miltenyi Biotec) following the MACS
separation protocol provided by the manufacturer.
Virus stocks and transductions
To generate viral stocks, 293T cells were co-transfected with the
proviral HIV-1 constructs and a plasmid (pHIT-G) expressing the
Vesicular StomatitisVirus G protein(VSG-G)[25,28]. The latter was
used to achieve comparable high initial infection levels for functional
analysis. However, all HIV-1 constructs contained intact env genes
and were thus replication competent following the first round of
infection. The medium was changed after overnight incubation and
virus was harvested 24 h later. Residual cells in the supernatants were
pelleted and the supernatants were stored at 270uC. Virus stocks
were quantified using a p24 antigen capture assay provided by the
NIH AIDS Research and Reference Reagent Program.
Infectivity assays
Virus infectivity was determined using TZM-bl and P4-CCR5
cells as described [65]. Briefly, the cells were sown out in 96-well-
dishes in a volume of 100 ml and infected after overnight
incubation with virus stocks containing 1 of p24 antigen produced
by transiently transfected 293T cells. Two days post-infection viral
infectivity was detected using the Gal screen kit from TROPIX as
recommended by the manufacturer. b-galactosidase activities were
quantified as relative light units per second (RLU/s) using the
Orion Microplate Luminomter.
Flow cytometric analysis
CD4, TCR-CD3, MHC-I, CD28 and eGFP reporter expression
in Jurkat T cells or human PBMC transduced with HIV-1 (NL4-3)
constructs coexpressing Nef and eGFP were measured as described
[25,28]. CD8, IL-2R, CD69 and PD-1 expression was measured by
standard FACS staining, using CD8 (BD Pharmingen, Clone RPA-
T8), CD25 (BD Pharmingen, Clone M-A251), CD69 (BD
Pharmingen, Clone FN50) and PD-1 (BD Pharmingen, Clone
MIH4) mAbs. For quantification of Nef-mediated modulation of
specific surface molecules, the levels of receptor expression (red
fluorescence)weredetermined for cellsexpressing a specificrange of
eGFP. The extent of downmodulation (n-fold) was calculated by
dividing the MFI obtained for cells infected with the nef-minus NL4-
3 control viruses by the corresponding values obtained for cells
infected with viruses coexpressing Nef and eGFP.
PBMC activation and apoptosis
Human PBMC were first stimulated with PHA (1 mg/ml) for 3
days. Subsequently, the cells were cultured in RPMI1640 (10%
FCS, 10 ng/ml IL-2), infected with various HIV-1 eGFP/Nef
constructs and cultured for another 2 days. At this time the PBMC
expressed very low levels of CD69 and IL-2R and hence had a
resting phenotype. Thereafter, the PBMC were treated a second
time with PHA and CD69 and IL-2R expression levels were
measured by FACS analysis one and four days later. The
frequency of virally infected apoptotic cells was determined using
the AnnexinV (AnV) Apoptosis Detection Kit (BD Bioscience) as
recommended by the manufacturer.
NFAT induction
Jurkat cells stably transfected with an NFAT-dependent
reporter gene vector [31] were either left uninfected or transduced
with HIV-1 Nef/eGFP constructs expressing various nef alleles.
Except for those cells used as controls, cultures were treated with
PHA (1 mg/ml; Murex). Luciferase activity was measured and n-
fold induction determined by calculating the ratio between
measured relative light units of treated samples over untreated
samples as described previously [28,31].
Statistical analysis
The activities of nef alleles derived from SMs with low (n=15) or
high (n=11) CD4
+ T cell counts and of the subgroups of animals
expressing nef alleles showing the highest (n=6) or lowest (n=6)
activities in CD3 and MHC-I modulation were compared using a
two-tailed Student’s t test. The PRISM package version 4.0
(Abacus Concepts, Berkeley, CA) was used for all calculations.
Protective Nef Functions
PLoS Pathogens | www.plospathogens.org 13 July 2008 | Volume 4 | Issue 7 | e1000107Accession numbers
GenBank accession numbers for previously described SIVsmm
nef sequences are DQ408682 to DQ408725 and for newly derived
sequences EU636907 to EU636923 (see Tables S1 and S2 for
further detail).
Supporting Information
Figure S1 Generation of HIV-1 NL4-3 constructs expressing
heterologous SIVsmm nef alleles. SIVsmm nef alleles were directly
amplified from plasma of infected SMs by RT-PCR [27]. For
cloning into the proviral NL4-3 IRES/eGFP constructs, the 39 end
of the HIV-1 env gene and the SIVsmm nef genes were fused by
splice-overlap-extension (SOE) PCR using outer primers contain-
ing HpaI and MluI restriction sites and overlapping inner primers
and cloned in bulk into the proviral constructs. The resulting
proviral constructs differed specifically in their nef genes.
Found at: doi:10.1371/journal.ppat.1000107.s001 (0.10 MB TIF)
Figure S2 SIVsmm Nef-mediated receptor modulation in Jurkat
cells and CD8-depleted PBMCs. Surface expression of CD3, CD4
and MHC-I on Jurkat cells (upper) and CD8-depleted PBMCs
(lower) infected with HIV-1 Nef/eGFP constructs expressing
eGFP alone (nef-) or together with indicated nef alleles. 239 specifies
the SIVmac239 Nef. Similar results were obtained in two
independent experiments.
Found at: doi:10.1371/journal.ppat.1000107.s002 (0.75 MB TIF)
Figure S3 Correlation between the efficiencies of Nef-mediated
CD4, CD3 and MHC-I downmodulation in Jurkat cells, PBMCs
and CD8-depleted PBMCs.
Found at: doi:10.1371/journal.ppat.1000107.s003 (0.10 MB TIF)
Figure S4 Correlation between the efficiency of CD3 and MHC-I
downmodulationbyNefandthenumberofCD4
+Tce ll si nSI V sm m
infected SMs. Correlation between (A, C) the absolute numbers and
(B, D) the percentages of CD4
+ T-cells in SIVsmm-infected SMs and
n-fold downmodulation of CD3 and MHC-I or the sum thereof. Nef
function was determined in PBMCsin both the presenceand absence
of CD8
+T cells. Nef alleles from the CD4high and CD4low groups of
SMs are color coded green and red, respectively.
Found at: doi:10.1371/journal.ppat.1000107.s004 (0.19 MB TIF)
Figure S5 Correlation between the efficiency of CD3 and
MHC-I downmodulation by Nef in CD8-depleted PBMCs and
immological features in SIVsmm infected SMs. Correlation
between (A) the number of proliferating CD4
+Ki67
+ T cells, (B)
CD95 expression levels of CD4
+ T-cells, (C) number of
CD8
+CD28
+ T cells and (C) percentage of naı ¨ve CD4
+ T cells
in SIVsmm-infected SMs and n-fold downmodulation of CD3 and
MHC-I. Assays were performed in PBMCs depleted of CD8
+ T
cells. Data derived from nef alleles derived from the CD4high and
CD4low groups of SMs are color coded green and red,
respectively and were confirmed in two independent experiments.
Found at: doi:10.1371/journal.ppat.1000107.s005 (0.15 MB TIF)
Figure S6 Effect of SIVsmm Nef alleles on the activation of
CD8-depleted PBMCs. (A) Levels of CD69, PD-1 and IL-2R
expression on CD8-depleted PBMCs transduced with HIV-1
constructs expressing Nef alleles from SIVsmm-infected SMs with
low (red) or high (green) CD4
+ T-cell counts. The mean
fluoresence activities (MFIs) of CD69, PD-1 and IL-2R expression
were determined at 1 and 2 days post-stimulation, respectively.
Correlation between the efficiency of Nef-mediated CD3 down-
modulation and (B) IL-2R, (C) PD-1 and (D) IL-2R surface
expression levels. Correlation between (E) PD-1 and CD69 and (F)
PD-1 and IL-2R expression. The results were confirmed in two
independent experiments.
Found at: doi:10.1371/journal.ppat.1000107.s006 (0.20 MB TIF)
Figure S7 Comparison of SIVsmm Nef alleles differing in their
ability to modulate cellular receptors and the responsiveness of T
cells to activation. Alignment of amino acid sequences of (A) the
SMhi and SMlow nef alleles, (B) the primary FCs clone 1 and FYb
clone 17 nef genes and two mutants thereof and (C) primary FBr nef
alleles. Mutagenized residues are indicated in bold and dots specify
amino acid identity.
Found at: doi:10.1371/journal.ppat.1000107.s007 (1.41 MB TIF)
Table S1 Functional activity of primary SIVsmm Nef alleles
tested in bulk. Functional activity of primary SIVsmm Nef alleles
tested in bulk. Nef-mediated n-fold receptor downmodulation was
calculated by dividing the MFI of cells infected with a nef-deficient
HIV-1 expressing a specific range of green fluorescence by the
corresponding number obtained for cells infected with HIV-1
constructs coexpressing Nef and eGFP. The results were
confirmed in three to five independent experiments. Viral
infectivity is given relative to that of SIVmac239 (100%) and
represents averages 6SD (n=6). The levels of NFAT-dependent
luciferase reporter activity in Jurkat cells infected with nef-defective
HIV-1 were set to 100%. Shown are averages (6SD) of triple
infections.
Found at: doi:10.1371/journal.ppat.1000107.s008 (0.01 MB PDF)
Table S2 Functional activity of primary and synthetic mutant
SIVsmm nef alleles. Functional activity of primary and synthetic
mutant SIVsmm nef alleles. Receptor modulation was calculated as
described in the legend to Table S1. The levels of CD69, PD-1
and IL-2R surface expression, of NFAT-dependent luciferase
reporter activities and of apoptotic PBMCs measured in cell
cultures infected with the nef-defective control virus were set to
100%. Abbreviations: G1, G2, Group 1 Nefs do not, and Group 2
Nefs do downregulate TCR-CD3. All values are averages derived
from two to four experiments.
Found at: doi:10.1371/journal.ppat.1000107.s009 (0.01 MB PDF)
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